Results 41 to 50 of about 2,777,517 (335)

Immunosuppressive Drugs in Early Systemic Sclerosis and Prevention of Damage Accrual

Arthritis Care &Research, EarlyView.
Objective Organ damage in patients with systemic sclerosis (SSc) in individual organs such as the lungs may be prevented by receiving immunosuppressive drugs (ISs). A new measure of global organ damage, the Scleroderma Clinical Trials Consortium Damage Index (SCTC‐DI), has allowed us to investigate whether receiving ISs may reduce global organ damage ...
Murray Baron, Mandana Nikpour, Dylan Hansen, Susanna Proudman, Wendy Stevens, on behalf of the Australian Scleroderma Interest Group and the Canadian Scleroderma Research Group, Joanne Sahhar, Nava Ferdowsi, Kathleen Morrisroe, Laura Ross, Gene Siew Ngian, Jennifer Walker, Janet Roddy, Lauren Host, Mohammed Osman, Peter Docherty, Paul Fortin, Marvin Jacob Fritzler, Genevieve Gyger, Alena Ikic, Niall Jones, Elzbieta Kaminska, Maggie Larche, Sophie Ligier, Ada Man, Ariel Masetto, Janet Pope, David Robinson, Tatiana Sofia Rodriguez‐Reyna, Mianbo Wang   +29 more
wiley   +1 more source

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

World Allergy Organization Journal, 2015
The purpose of this brief communication is to highlight emerging evidence to existing guidelines regarding potential benefits of supporting early, rather than delayed, peanut introduction during the period of complementary food introduction in infants ...
David M. Fleischer, Scott Sicherer, Matthew Greenhawt, Dianne Campbell, Edmond S. Chan, Antonella Muraro, Susanne Halken, Yitzhak Katz, Motohiro Ebisawa, Lawrence Eichenfield, Hugh Sampson   +10 more
doaj  

GUIMIT 2019, Mexican Guideline on Immunotherapy. Guideline on the diagnosis of IgE-mediated allergic disease and immunotherapy following the ADAPTE approach

Revista Alergia México, 2019
Background: In Mexico, allergen immunotherapy (AIT) and immunotherapy with hymenoptera venom (VIT) is traditionally practiced combining aspects of the European and American school.
Désirée Larenas-Linnemann, Jorge A. Luna-Pech, Noel Rodríguez-Pérez, Mónica Rodríguez-González, Alfredo Arias-Cruz, María Virginia Blandón-Vijil, María del Carmen Costa-Domínguez, Blanca E. Del Río-Navarro, Alan Estrada-Cardona, Elsy Maureen Navarrete-Rodríguez, José Antonio Ortega-Martell, César Fireth Pozo-Beltrán, Herson Brito-Díaz, María del Rosario Canseco-Raymundo, Enrique Emanuel Castelán-Chávez, Margarita Gabriela Domínguez-Silva, Alberto José Escalante-Domínguez, José Luis Gálvez-Romero, María Guadalupe García-Reyes, Javier Gómez-Vera, Sandra Nora González-Díaz, María Gracias Belinda Guerrero-Núñez, Dante Hernández-Colín, Alejandra Macías-Weinmann, David Alejandro Mendoza-Hernández, Néstor Alejandro Meneses-Sánchez, María Dolores Mogica-Martínez, Carol Vivian Moncayo-Coello, Manuel Montiel-Herrera, Patricia O’Farril-Romanillos, Ernesto Onuma-Takane, Margarita Ortega-Cisneros, Lorena Rangel-Garza, Héctor Stone-Aguilar, Carlos Torres-Lozano, Edna Venegas-Montoya, Guillermo Wakida-Kusunoki, Carlos Macouzet-Sánchez, Armando Partida-Gaytán, Aída Inés López-García, Ana Paola Macías-Robles, María de Jesús Ambriz-Moreno, Amyra Ali Azamar-Jácome, Carlos Báez-Loyola, Claudia Yusdivia Beltrán-De Paz, Chrystopherson Caballero-López, Juan Carlos Fernández de Córdova-Aguirre, Roberto Fernández-Soto, José Santos Lozano-Sáenz, José Joel Oyoqui-Flores, Roberto Osorio-Escamilla, Fernando Ramírez, Daniela Rivero-Yeverino, María del Socorro Orozco-Martínez, María Isabel Rojo-Gutiérrez, Eric Martínez, Miguel Alejandro Medina-Ávalos   +56 more
doaj   +1 more source

Incidence of Side Effects Associated With Acetaminophen in People Aged 65 Years or More: A Prospective Cohort Study Using Data From the Clinical Practice Research Datalink

Arthritis Care &Research, EarlyView.
Objective The main objective of this study is to examine the safety of oral acetaminophen at its therapeutic dose in adults aged ≥65 years. Methods This population‐based cohort study used the Clinical Practice Research Datalink‐Gold data. Participants were aged ≥65 years registered with a UK general practice for at least 12 months between 1998 and 2018.
Jaspreet Kaur, Georgina Nakafero, Abhishek Abhishek, Christian Mallen, Michael Doherty, Weiya Zhang   +5 more
wiley   +1 more source

CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes

Journal of Asthma and Allergy, 2021
Wannada Laisuan,1 Chamard Wongsa,2 Chirawat Chiewchalermsri,3 Torpong Thongngarm,2 Ticha Rerkpattanapipat,1 Pansa Iamrahong,4 Chulapha Ruangwattanachok,4 Sira Nanthapisal,5 Mongkhon Sompornrattanaphan2 1Division of Allergy, Immunology and Rheumatology ...
Laisuan W, Wongsa C, Chiewchalermsri C, Thongngarm T, Rerkpattanapipat T, Iamrahong P, Ruangwattanachok C, Nanthapisal S, Sompornrattanaphan M   +8 more
doaj  

An Effective Membrane Model of the Immunological Synapse [PDF]

, 2003
The immunological synapse is a patterned collection of different types of receptors and ligands that forms in the intercellular junction between T Cells and antigen presenting cells (APCs) during recognition. The synapse is implicated in information transfer between cells, and is characterized by different spatial patterns of receptors at different ...
arxiv   +1 more source

Association of Changes in Hand Pain With BMI, Employment, and Mental Well‐Being Over Four Years in Patients With Hand Osteoarthritis

Arthritis Care &Research, EarlyView.
Objective We aimed to characterize patients with hand osteoarthritis (OA) with deteriorating or improving hand pain and to investigate patients achieving good clinical outcome after four years. Methods We used four‐year annual Australian/Canadian Hand Osteoarthritis Index (AUSCAN) pain subscale (range 0–20) measurements from the Hand OSTeoArthritis in ...
Coen van der Meulen, Lotte A. van de Stadt, Saskia J. Buck, Frits R. Rosendaal, Sietse E. S. Terpstra, Margreet Kloppenburg   +5 more
wiley   +1 more source

Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study

American Journal of Hematology, Volume 98, Issue 1, Page 11-22, January 2023., 2023
Treatment process evolution. *The target TNC for BMH was ≥6 × 108/kg per patient. The Group B1 patient received lovo‐cel produced using both the original and refined manufacturing process, and the Group B2 patient received lovo‐cel produced using only the refined manufacturing process.
Julie Kanter, Alexis A. Thompson, Francis J. Pierciey Jr, Matthew Hsieh, Naoya Uchida, Philippe Leboulch, Manfred Schmidt, Melissa Bonner, Ruiting Guo, Alex Miller, Jean‐Antoine Ribeil, David Davidson, Mohammed Asmal, Mark C. Walters, John F. Tisdale   +14 more
wiley   +1 more source

Optimal Allocation of Gold Standard Testing under Constrained Availability: Application to Assessment of HIV Treatment Failure [PDF]

, 2020
The World Health Organization (WHO) guidelines for monitoring the effectiveness of HIV treatment in resource-limited settings (RLS) are mostly based on clinical and immunological markers (e.g., CD4 cell counts). Recent research indicates that the guidelines are inadequate and can result in high error rates.
arxiv   +1 more source

“It's Just Good Science”: A Qualitative Study Exploring Equity, Diversity, and Inclusion in Canadian Arthritis Research

Arthritis Care &Research, EarlyView.
Objective Despite knowledge that health outcomes vary according to patient characteristics, identity, and geography, including underrepresented populations in arthritis research remains a challenge. We conducted interviews to explore how researchers in arthritis have used equity, diversity, and inclusion (EDI) principles to inform their research ...
Megan M. Thomas, Mark Harrison, Cheryl Barnabe, Charlene E. Ronquillo, J. Antonio Avina‐Zubieta, Anna Samson, Michael Kuluva, Natasha Trehan, Mary A. De Vera   +8 more
wiley   +1 more source